Johnson & Johnson announces a settlement of up to US$5.5 billion to resolve outstanding lawsuits that allege the company’s talc products, including baby powder, are linked to ovarian cancer. Multiple outlets report the agreement is designed to end a large portion of litigation brought by tens of thousands of plaintiffs. The claims center on assertions that exposure to talc used in Johnson & Johnson products causes or contributes to ovarian cancer. The settlement amount is described as “up to” US$5.5 billion, indicating that the final payout can depend on the resolution process and eligibility of claims. Coverage also characterizes the settlement as a major resolution in the long-running talc litigation, bringing an end to significant legal proceedings related to those allegations. The reports present the announcement as a company action to settle claims rather than an admission of wrongdoing, though specific terms and any liability determinations are not detailed in the provided excerpts. The settlement is reported across several outlets as a landmark agreement affecting the future of the talc-related court cases.